Open Labeled Study Product On The Blind Case (Doc ID 2851093.1)

Last updated on JULY 13, 2023

Applies to:

Oracle Life Sciences Argus Safety - Version 8.1.1 and later
Information in this document applies to any platform.

The blind study has several study products in study settings under (menu) Argus Console > Business configuration > Studies > ARM section.

The product type is set as "Additional Study Drug" for open labeled product.

When the case was created with this blind study, the open product was not added as "study drug" in the product tab.

Why? How does product type "Additional Study Drug" work for the blind study?

	To view full details, sign in with your My Oracle Support account.
	Don't have a My Oracle Support account? Click to get started!

In this Document

Goal

My Oracle Support provides customers with access to over a million knowledge articles and a vibrant support community of peers and Oracle experts.